0001209191-23-036529.txt : 20230612 0001209191-23-036529.hdr.sgml : 20230612 20230612204818 ACCESSION NUMBER: 0001209191-23-036529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schneyer Mark C. CENTRAL INDEX KEY: 0001899977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 231010030 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-08 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001899977 Schneyer Mark C. C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 EVP, Chief Financial Officer 0 Common Stock 2023-06-08 4 M 0 1893 0.00 A 23798 D Common Stock 2023-06-08 4 S 0 974 25.02 D 22824 D Restricted Stock Units 2023-06-08 4 M 0 1893 0.00 D Common Stock 1893 1893 D The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Acadia common stock. The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024. /s/ Austin D. Kim, Attorney-in-Fact 2023-06-12